NYSE - Delayed Quote USD

Integer Holdings Corporation (ITGR)

120.92 +1.92 (+1.61%)
At close: May 17 at 4:00 PM EDT
118.70 -2.22 (-1.84%)
After hours: May 17 at 7:10 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Joseph W. Dziedzic President, CEO & Director 3.24M 713.51k 1968
Mr. Diron Smith Executive VP & CFO 651.22k -- 1974
Mr. McAlister C. Marshall II Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary 854.89k -- 1970
Mr. Kirk K. Thor Executive VP & Chief Human Resources Officer 791.64k -- 1964
Mr. Payman Khales President of Cardio & Vascular 1.14M -- 1970
Mr. John Harris Executive Vice President of Global Operations & Manufacturing Strategy 521.18k 42.65k 1960
Mr. Tom P. Thomas VP, Corporate Controller & Principal Accounting Officer -- -- 1971
Mr. Andrew Senn Senior Vice President of Strategy, Business Development & Investor Relations -- -- 1982
Ms. Margaret Carthy Executive VP of Global Quality & Regulatory Affairs -- -- 1964
Mr. Jim Stephens President of Cardiac Rhythm Management & Neuromodulation -- -- 1974

Integer Holdings Corporation

5830 Granite Parkway
Suite 1150
Plano, TX 75024
United States
214 618 5243 https://www.integer.net
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
10,500

Description

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Corporate Governance

Integer Holdings Corporation’s ISS Governance QualityScore as of May 1, 2024 is 2. The pillar scores are Audit: 4; Board: 2; Shareholder Rights: 2; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 25, 2024 at 12:00 PM UTC - July 29, 2024 at 12:00 PM UTC

Integer Holdings Corporation Earnings Date

Recent Events

May 14, 2024 at 5:40 PM UTC

at Bank of America Health Care Conference

April 25, 2024 at 1:00 PM UTC

Q1 2024 Earnings Call

April 25, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 8, 2024 at 12:00 AM UTC

ARS: Annual Report to Shareholders

March 19, 2024 at 3:15 PM UTC

at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual)

February 20, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 15, 2024 at 2:00 PM UTC

Q4 2023 Earnings Call

February 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 22, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

January 10, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers